RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Molecular Data Stock

Molecular Data ROA 2024

Molecular Data ROA

0

Ticker

MKD

ISIN

US60852L1061

WKN

A2PYCA

In 2024, Molecular Data's return on assets (ROA) was 0, a 0% increase from the 0 ROA in the previous year.

Molecular Data Aktienanalyse

What does Molecular Data do?

Molecular Data Inc. is a leading technology company specializing in the use of big data, artificial intelligence (AI), and blockchain technology in the chemical and pharmaceutical industry. The company was founded in 2014 and is headquartered in Shanghai, China. Molecular Data Inc. has a comprehensive database consisting of millions of chemical compounds, which aids chemists, pharmaceutical companies, and researchers in identifying, exploring, and developing new drugs. The company places great importance on integrating data and technologies to accelerate and improve drug development. Molecular Data Inc. provides cloud-based solutions based on the analysis of big data through AI algorithms and blockchain technology. It offers platforms, as well as consulting and training services, to support customers in efficiently utilizing the platforms. The company's main products include the MDL platform, which enables the integration of data, knowledge, and algorithms to accelerate drug development processes. The MDL platform is a cloud-based system that provides access to a database of millions of compounds and allows users to receive real-time results. Molecular Data Inc. also offers a blockchain-based platform for the chemical and pharmaceutical industry, enhancing the transparency and security of data and information. The platform facilitates secure data exchange between different companies and regulatory authorities, providing improved control and monitoring of data. Another important service provided by Molecular Data Inc. is consulting and training for companies in implementing big data, AI, and blockchain into their workflows. The company aims to equip its customers with the necessary skills and knowledge to optimize their business processes and increase competitiveness. Molecular Data Inc. is divided into several divisions to ensure efficient collaboration and product development. These divisions include research and development, sales and marketing, finance and administration, and information technology. The company strives to expand its business through strategic partnerships and acquisitions. It has already completed several acquisitions to strengthen its expertise in big data, AI, and blockchain. Through these strategic measures, the company has been able to offer its customers a comprehensive range of products and services to enhance performance and increase competitiveness. Overall, Molecular Data Inc. is a significant company in the chemical and pharmaceutical industry that specializes in the integration of data and technologies to enhance process efficiency and speed. The company aims to strengthen its position as a market leader through innovation and strategic partnerships. Molecular Data ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Molecular Data's Return on Assets (ROA)

Molecular Data's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Molecular Data's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Molecular Data's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Molecular Data’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Molecular Data stock

What is the Return on Assets (ROA) of Molecular Data this year?

The Return on Assets (ROA) of Molecular Data is 0 undefined this year.

What was the ROA of Molecular Data compared to the previous year?

The ROA of Molecular Data has increased by 0% compared to the previous year.

What consequences do high ROA have for investors of Molecular Data?

A high ROA is advantageous for investors of Molecular Data, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Molecular Data?

A low ROA can be unfavorable for investors of Molecular Data as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Molecular Data affect the company?

An increase in ROA of Molecular Data can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Molecular Data impact the company?

A reduction in the ROA of Molecular Data can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Molecular Data?

Some factors that can influence the ROA of Molecular Data include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Molecular Data important for investors?

The ROA of Molecular Data is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Molecular Data take to improve ROA?

To improve ROA, Molecular Data can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Molecular Data pay?

Over the past 12 months, Molecular Data paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Molecular Data is expected to pay a dividend of 0 CNY.

What is the dividend yield of Molecular Data?

The current dividend yield of Molecular Data is .

When does Molecular Data pay dividends?

Molecular Data pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Molecular Data?

Molecular Data paid dividends every year for the past 0 years.

What is the dividend of Molecular Data?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Molecular Data located?

Molecular Data is assigned to the 'Cyclical consumption' sector.

Wann musste ich die Aktien von Molecular Data kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Molecular Data from 9/9/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 9/9/2024.

When did Molecular Data pay the last dividend?

The last dividend was paid out on 9/9/2024.

What was the dividend of Molecular Data in the year 2023?

In the year 2023, Molecular Data distributed 0 CNY as dividends.

In which currency does Molecular Data pay out the dividend?

The dividends of Molecular Data are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Molecular Data

Our stock analysis for Molecular Data Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Molecular Data Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.